1. Home
  2. PRPO vs SYRA Comparison

PRPO vs SYRA Comparison

Compare PRPO & SYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • SYRA
  • Stock Information
  • Founded
  • PRPO N/A
  • SYRA 2020
  • Country
  • PRPO United States
  • SYRA United States
  • Employees
  • PRPO N/A
  • SYRA N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • SYRA Other Specialty Stores
  • Sector
  • PRPO Industrials
  • SYRA Industrials
  • Exchange
  • PRPO Nasdaq
  • SYRA Nasdaq
  • Market Cap
  • PRPO 8.8M
  • SYRA 8.5M
  • IPO Year
  • PRPO N/A
  • SYRA 2023
  • Fundamental
  • Price
  • PRPO $5.08
  • SYRA $1.31
  • Analyst Decision
  • PRPO
  • SYRA
  • Analyst Count
  • PRPO 0
  • SYRA 0
  • Target Price
  • PRPO N/A
  • SYRA N/A
  • AVG Volume (30 Days)
  • PRPO 9.6K
  • SYRA 32.4K
  • Earning Date
  • PRPO 08-15-2024
  • SYRA 08-13-2024
  • Dividend Yield
  • PRPO N/A
  • SYRA N/A
  • EPS Growth
  • PRPO N/A
  • SYRA N/A
  • EPS
  • PRPO N/A
  • SYRA N/A
  • Revenue
  • PRPO $15,812,000.00
  • SYRA $6,079,133.00
  • Revenue This Year
  • PRPO $75.18
  • SYRA $70.86
  • Revenue Next Year
  • PRPO N/A
  • SYRA N/A
  • P/E Ratio
  • PRPO N/A
  • SYRA N/A
  • Revenue Growth
  • PRPO 61.64
  • SYRA 3.73
  • 52 Week Low
  • PRPO $4.31
  • SYRA $0.81
  • 52 Week High
  • PRPO $8.99
  • SYRA $8.37
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 48.60
  • SYRA 44.96
  • Support Level
  • PRPO $4.32
  • SYRA $1.27
  • Resistance Level
  • PRPO $5.80
  • SYRA $1.39
  • Average True Range (ATR)
  • PRPO 0.43
  • SYRA 0.07
  • MACD
  • PRPO 0.06
  • SYRA 0.00
  • Stochastic Oscillator
  • PRPO 51.68
  • SYRA 31.25

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About SYRA Syra Health Corp.

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.

Share on Social Networks: